Atlas Trials

Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight

Clinical trial NCT02313220 · COMPLETED

Trial details

NCT number
NCT02313220
Sponsor
Uppsala University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2014-12-01
Primary completion
2016-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.